10-K
COPYTELE, INC. 10-K
- Company
- Anixa Biosciences Inc
- Filed
- January 29, 2010
- Period of Report
- October 31, 2009
- Accession Number
- 0001157523-10-000472
A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →